acitretin has been researched along with Noonan Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abadie, C; Aouinti, S; Baumann, C; Bessis, D; Best, M; Bourrat, E; Bursztejn, AC; Capri, Y; Cavé, H; Chiaverini, C; Coubes, C; Geneviève, D; Giuliano, F; Hadj-Rabia, S; Jacquemont, ML; Lacombe, D; Lyonnet, S; Mallet, S; Mazereeuw-Hautier, J; Miquel, J; Molinari, N; Morice-Picard, F; Parfait, B; Pernet, C; Philip, N; Pinson, L; Pouvreau, N; Sarda, P; Sigaudy, S; Verloes, A; Vial, Y | 1 |
1 other study(ies) available for acitretin and Noonan Syndrome
| Article | Year |
|---|---|
Dermatological manifestations in cardiofaciocutaneous syndrome: a prospective multicentric study of 45 mutation-positive patients.
Topics: Acitretin; Administration, Cutaneous; Administration, Oral; Adolescent; Child; Child, Preschool; Costello Syndrome; Diagnosis, Differential; Ectodermal Dysplasia; Facies; Failure to Thrive; Female; France; Genetic Association Studies; Heart Defects, Congenital; Humans; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mutation; Noonan Syndrome; Prospective Studies; Proto-Oncogene Proteins B-raf; Sirolimus; Treatment Outcome; Young Adult | 2019 |